Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile

Caloric restriction (CR) and down-regulation of the insulin/IGF pathway are the most robust interventions known to increase longevity in lower organisms. However, little is known about the molecular adaptations induced by CR in humans. Here, we report that long-term CR in humans inhibits the IGF-1/i...

Full description

Bibliographic Details
Main Authors: Mercken, Evi M. (Author), Crosby, Seth D. (Author), Lamming, Dudley W. (Contributor), JeBailey, Lellean (Author), Krzysik-Walker, Susan (Author), Villareal, Dennis T. (Author), Capri, Miriam (Author), Franceschi, Claudio (Author), Zhang, Yongqing (Author), Becker, Kevin (Author), de Cabo, Rafael (Author), Fontana, Luigi (Author), Sabatini, David (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Whitehead Institute for Biomedical Research (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Sabatini, David M. (Contributor)
Format: Article
Language:English
Published: Wiley Blackwell, 2015-04-23T17:39:19Z.
Subjects:
Online Access:Get fulltext
Description
Summary:Caloric restriction (CR) and down-regulation of the insulin/IGF pathway are the most robust interventions known to increase longevity in lower organisms. However, little is known about the molecular adaptations induced by CR in humans. Here, we report that long-term CR in humans inhibits the IGF-1/insulin pathway in skeletal muscle, a key metabolic tissue. We also demonstrate that CR induces dramatic changes of the skeletal muscle transcriptional profile that resemble those of younger individuals. Finally, in both rats and humans, CR evoked similar responses in the transcriptional profiles of skeletal muscle. This common signature consisted of three key pathways typically associated with longevity: IGF-1/insulin signaling, mitochondrial biogenesis, and inflammation. Furthermore, our data identify promising pathways for therapeutic targets to combat age-related diseases and promote health in humans.
American Federation for Aging Research
National Center for Research Resources (U.S.) (Grant UL1 RR024992)
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) (Grant P30DK056341)